Biogen

Biogen Inc.
	Headquarters in Cambridge, Massachusetts
Formerly	Biogen Idec Inc. (2003–2015)
Company type	Public
Traded as	Nasdaq: BIIB; Nasdaq-100 component; S&P 500 component;
Industry	Biotechnology
Founded	1978
Founders	Kenneth Murray; Phillip Allen Sharp; Walter Gilbert; Heinz Schaller; Charles Weissmann;
Headquarters	Cambridge, Massachusetts, U.S.
Key people	Caroline Dorsa (chairman); Chris Viehbacher (CEO);
Products	Avonex; Fampyra; Plegridy; Tecfidera; Tysabri; Spinraza;
Revenue	US$9.836 billion (2023)
Operating income	US$1.297 billion (2023)
Net income	US$1.162 billion (2023)
Total assets	US$26.84 billion (2023)
Total equity	US$14.80 billion (2023)
Number of employees	7,570 (2023)
Website	biogen.com
	Footnotes / references;

Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide. Biogen operates in Argentina, Brazil, Canada, China, France, Germany, Hungary, India, Italy, Japan, Mexico, Netherlands, Poland, Sweden, and Switzerland.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.